The 4th Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting that considers pre-clinical developmenttranslationmanufacturingsupply and storage of allogeneic cell therapies to improve the accessibility and efficacy of patient care worldwide.

400+ experts from pharma, biotech and leading academia are expected to attend in Boston, USA 9-12 May 2022 to uncover best-in-class approaches to overcome.

Alan Trounson – Cartherics’ CEO will be there.

Read more about it here:

Program Details